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SUMMARY
To determine the possible biochemical consequences of prolonged weigh0.essness on liver
function, tissue samples from rats that had flown aboard Cosmos 1887 were analyzed for hepatic
protein, glycogen and lipids as well as the activities of a number of ke.veuzymes involved in
metabolism of these compounds and xenobiotics. Among the parameters measured, the major
differences were elevations in the hepatic gly,.;ogencontent andHMG-CoA reductase activities of
the rats flown on Cosmos 1887, and a decrease in the amount of microsomal cytochrome P450and
the activity of aniline hydroxylase, a cytochrome P450-dependent enzyme. Decreases in these two
indices of the microsomal mixed-function oxidase system indicate that spaceflight may compromise
the ability of liver to metabolize drugs and toxins. 'i'he higher HMG-CoA reductase correlated with
elevated levels of serum cholesterol. Other changes included somewhat higheablood glucose,
creatinine, SGOT, and much greater alkaline phosphatase and BUN. These results generally
support the earlier observation of changes in these parameters (Merrill et al., Am. J. Physiol.
252:R22-R226, 198/). The importance of these alterations in liver function is not l_own;
however, they have the potential to complicate long-term spaceflight.
INTRODUCYION
The experience of weightlessness during spaceflight and the stresses associated with lift-off and
reentry cause a number of physiological changes in astronauts and experimental animals. These
include changes in fluid distribution, electrolyte balance, bone strength and growth, nitrogen
balance, and lean body mass, inter alia (1-10). Many of these changes appear to be due to the lack
of exercise, that occurs in a weightless environment, but whether others represent the influence of
long-term stress or other factors remains at issue.
Among the changes that have been observed during and after spaceflight are elevated adrenal
steroid secretion and altered concentrations of various lipids and carbohydrates in blood and other
tissues. Changes in hepatic concentrations of glycogen, lipids, and enzymes involved in
metabolism of these compounds occurred during or after spaceflight in the Cosmos biosatellites (1-
3,5,6,11). Secretion of a number of hormones that affect enzyme systems in liver may be altered
by space flight; these include adrenal steroids, insulin, and growth hormone (3,8).
Since liver is an important site of nutrient and xenobiotic metabolism, further study of the effects of
spaceflight on this organ appeared warranted. The inclusion of experimental animals aboard
Spacelab 3 allowed us to conduct analyses of some of the key hepatic enzymes of cholesterol,
glycerolipid, and sphingolipid biosynthesis (10) as well as quantiation of glycogen, protein, and
lipids. These analyses revealed significantly lower activities for some but not all of the enzymes
tested, suggesting that spaceflight can cause specific perturbations in liver function.
Based on these previous findings, we propose that several aspects of hepatic function are altered
by spaceflight. In particular, ,'hese include key enzymes of cholesterol and sphingolipid
,_ biosynthesis and drug metabolism (e.g., cytochrome P4_). DescriL_t in this reportareadditir _,,,'.
, data from analyses of liver and senlm samples from rats flown on Cosmos 1887 that support this
hypothesis.
MATERIALS AND METHODS
Each group contained five male rats of Czechoslovakia-Wistar origin. They weighed between 300
and 400 g and were fed 55 g/day of a paste diet, and given water ad libil_m. The animals were
flown for 14 days and maintained on a regular cycle of 16 h of light/8 h of dark. The animals were
killed between 53 and 56 hours after landing and the livers were immediately frozen and stored at
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t-80o. Additional i_'ffonmtionabout thehistoryof the anim_'_andparametr_ such as the organ
weights will be provided by the other participantsof this study (e.g., Dr. RichardE. Grindeland,
NASA).
T'_. The liver samples were thawed, homogoniz_, and_ntrifuged following
fairly standardprotocols to yield a microsomal fracdon anda high-speed (cytosolic) fraction as
described previously (10). We have found this procedure to recover microsomes in approximately
78% yield with little contamination with markersof other subfra_ons (12). Aliquots of the
original homogenate, microsomes, and cytosol were storedat -80° until use. Individual aliquots
were used for each assay to minimize losses of activity during free_w.
Serum analy_s. The serum analyses were conducted using a COBAS Bio-centrifugal Analyzer
calibratedwith certified clininalslandards.
_. Total proteinwas assayed using a modification of the method of Lowry et al.
(13) with bovine serumalbumin as the standard.
Glycogen analyses. Liver glycogen was quantitatedusing themethod oi Johnson andFusaro (14)
andrabbit liver glycogen (Sigma Type HI) as the standard.
Lipid analyses, The lipids were extractedas described before (10) using essentially the method of
Bligh and Dyer 05) and analyzed for _glyccrides andcholesterol using the COBAS Analyzer.
Phospholipids were quantitated by assaying the amount of organic-solvent soluble phosphate, and
the total sphingolipids were estimated by analysis of the sphingosine content after acid hydrolysis
(16). Free sphingosine was quantitatedby high-performance liquid chromatography (17).
Enzyme assays. Most of the enzyme assays were conducted as described previously (10). Fatty
acyl-CoA synthetase was assayed with [3H]palmitic acid as the substrate(18), and HMG-CoA
reductase was assayed as described by Shapiroet al. (19), except that the [14C]-HMG-CoA
_ concentration was 25 gM. Serine palmitoyltransferase was assayed using [3H]scrine (12,21) and
glycerol 3-phosphate acyltransferase using [3H]glycerol 3-phosphate (21). Cytochrome P450 was
measured spectrophotometrically (22), and aniline hydroxylase was determined as described by
Gram et al. (23,24).
Tyrosine aminowansferase (25) and glutathione S-transferase (26) were assayed as described;
cystathionase was measured by its ability to produce hydrogen sulfide from cysteine, using assay
method HIof Stipanuk and Beck (27). Alkaline phosphamsc was analyzed as part of the COBAS
centrifugal analyzer.
DNA measurement. DNA was quantitated by the method of Fiszer-Szafarz et al. (28) using calf
thymus DNA as the standard.
i Statistical methods Except where otherwise noted, the data are given as the means _+the standard
deviation for n=5 in each group.
RESULTS
General effects of spaceflighton liver. The rats flown on Cosmos 1887 had slighly lower body
weights than either the synchronous or vivarium controls; however, the liver weights were _imilar(Table 1). The groups were also similar in amounts of total liver protein, cytosohc protein,
triglycerides, cholesterol and sphingolipids; however, the flight group was somewhat lower in
microsomal protein (but only on a per g of liver basis) and Lomlphospholipids. Liver DNA was
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lowest for the flight rats(ca. 28% lower than the synchronous controls). The major differences
were seen in liver glycogen, which was much lower for the vivariumrats and highest for the flight
animals (2-fold higher than the synchronous controls). There appearedto b¢ an inverse
relationshipbetween the amountsof DNA mid glycogen_which indicates that a partialexplanation
for the lower cell number per g of tissue is loading of the liver with glycogen.
Liverenzymes of ratsafter spaceflight. All of the cytosolic enzymes examined exhibited s_.milar
activities mnong the three groups. Even tyrosine aminott_sferase, which is highly sensitive to
changes in the hormonal statusthe animal, was not alteredsignificantly (Table 2). Liver alkaline
phosphatase,which is primarilya plasma membrane enzyme, appearedslightly higher for the
synchronous controls (58.0 + 13.7 units/g of liver) than for the flight group (48.8 + 3.8 units/g of
live), but the differences were not statistically significant.
Much largerdifferences were seen in microsomal enzymes (Table 3), without a single trend(i.e.,
some activities inc_ased while othersdecreased);hence, the rats thathadundergone spaceflight
underwentselective changes in microsomal enzymes. HMG-CoA reductase was over 2- fold
higher for the flight rats versus both vivarium andsynchronous controls ('Fable3), and this
correlatedwith thehigher serumcholesterol (Fig. 1). Serine palmitoyltransferaseandfatty acyl-
CoA synthetase were also elevated (by 41% and 58%, respectively), but only on a per g of liver
basis.
Cytochrome P450was slightly lower in the flight group (14%), and this persisted when the data
were compared on per g of liver (38%) and per 100 g of body weight (21%) bases. Aniline
hydroxylase, a member of the microsomal mixed-function oxidase system thatutilizes cytochrome
P450,was also lower in the flight group(Table 3). Altogether, the similar depressions in
cytochrome P450and aniline hydroxylasc (Fig. 2) indicate that the xenobiotic metabolizing system
is somewhat depressed in the animals that underwent spaceflight.
Effects of spaceflight on serumcomponents. As a broader indicator of the overall biochemical
i statusof these animals, a standardprofile of serumc-,mponcnts was obtained (Table 3). Total
: protein, albumin, glucose, bilirubin, Ca2+, K+, and phosphate were virtially identical for the flight
group and the synchronous controls.
Markers of muscle and tissue protein trauma (BUN, Crcatine,AST, alkaline phosphatase, and
lactate dehydrogenase) were consistently elevated in the flight groups (BUN was 144% higher than
the synchronous controls). Furthermore,the flight animals were hypcrlipidemic, with significant
elevations in serum cholesterol (67%) and to a lesser extent triglycerides (16%).
DISCUSSION
Because there was a two day period between the landing of Cosmos 1887 and the removal of the
livers for these biochemical analyses, the results of this studyarc more likely to reflect the
combination of spaceflight and the responses of the rats during a post-flight recovery period than to
changes due to spaceflight alone. Activities that change with a short half-time, therefore, may
easily readjust during or after landing, whereas parameters that require several days to change will
remain near the values attained during spaceflight. Nonetheless, many of the findings of this study
agreed closely with previous biochemical analyses that were conducted with a shorter lag time.
The most significant results obtained from this analysis of liver function after spaceflight include
the findings that glycogen content was elevated in the flight group, that these animals were
hypeflipidemic (and had elevations in the initial enzymes of cholesterol and sphingolipid biosyn-
thesis), and that cytochrome P450values were lower than for the synchronous control group.
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The major difference from the previousstudies (1,10) was m the increase in HMG-CoA reductase
activity, which was lower in ratsfrom Spacelab 3. It is clear from these,analyses of flight rats that
there arespecific and unexplainedchanges in the activities of the initial enzymes of cholesterol and
sphingolipid biosynthesis. This finding may be _t, since these lipi& areprimarily involved
in cell sine-acephenomena, such as the functioning of enzymes andreceptors, cell-to-ceE
communication, cell-to-surface antigenicity.,andsome a_cts of nerve impulse tr_smission.
Cholesteroland sphingomyelin are both found in lipoproteins,and thesechanges may relate as
much to the levels of circulating lipids as to those in liver.
Serumcholesterol has been reportedto decrease duringboth Apollo and Skylab missions (4,8).
However, plasma cholesterol was higher for the rats on Spacelab 3 (29) and this Cosmos flight,
which might indicate that lipoprotein cholesterolwas removed from circulationmore slowly for
these animals. Additional experin_ts are needed to explain thesediscrepancies.
The largedifference in hepaticglycogen contentbetween flight and control groups confirms the
earli_ observation wi,_hSpacelab3. Smaller increases in glycogen content have been observed
after other missions, as well as significantly decreased activity of glycogen phosphorylase (1,2);
and increased glycogen was noted also in heart and skeletal muscle. Since the animals hadeaten
- little dtu'ingtheprevious hours, the differences observed may relate to reduced glycogen
bre_&downin the flight group (however, the synchronous group were fed according to the .same
: schedule). Since hepaticglycogenolysis and gluconeogenesis are critical in maintaining normal
:: blood sugarlevels, it is importantto determinewhether these processes were alteredduring
, we!_tlessness; blood glucose was the same (or slightly elevated) in the flight group at the time of
sampling, as has been seen previously (10).
The indicationthat cytochrome P450was lower in liver from the flight group confirmed the earlier
finding with Spacelab 3. This enzyme proteinis involved in themetabolism of steroid hormones
anda varietyof xenobiotics, including antibiotics and ot!_-rdrugs;hence, decreases might reduce
the activity of such systems. This was demonstrated_.nthe lower activity of _iline hydroxylase in
the flight group. Although these differences were smali, the fact that they were seen in two indices
of the microsomalmixed function oxidase system lends credence to their validity. The
implications of this effect of spaceflighton the body's _ility to metabolize drugshave not been
explored; however, it could limit the abilityof an animal to detoxffy various drugsand other
compounds, anddiminish the potencyof drugsthatact after bioactivation by the cytochrome P450
system.
We conclude thatspaceflightsignificantly alters liver functionin a numberof ways. Changes in
glycogen and lipid metabolism are probablyconsequences of weightlessness, and drug metabolism
may also be altered. Because the liver functions to regulate supply, distribution,anddeposition of
numerouscompounds thatareeitherrequired by other organsor that,:an be toxic to them, the
bearingsof these findings on long-term adaptationto weightlessness should be evaluated in future
work. In the furoreit will t'e essential to obtainsamples takenin flight or shortly after landing to
,!
permit valid measurements of these parameters.
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TABLE 1.
Liver Protein, Glycogen, and Lipid Analyses
Vivarium Synchronous Flight
(Mean + SD)
Body weight (g) 342 ± 17.2 ,.,,,.,_'an±13.0 303.2-1- 5.4
Liver weight (g) 8.27:1:0.67 8.86 + 0.42 9.96 4- 3.16
LiverDNA(mg/gliver) 5.11 :!: 0.36 3.84:1:0.83 2.75+ 0.73
(rag/liver) 42.3 ± 3,4 34.0 :!: 7.4 27.4 + 8.7
(rng/100g B.W.) 12.4 + 1.0 9.7 + 2.1 9.0 + 2.9
Liver protein
(mg/g liver) 213 + 9 215 ± 15 228 :t: 19
(g/liver) 1.76 + 0.14 1.90 ± 0.1 2.27 + 0.72
(mg/100 g B.W.) 0.51 + 0.04 0.54 + 0.03 0.75 + 0.23
Microsomal protein
(mglg liver) 2.8 + 0.2 3.3 :!: 0.3 2.4 + 0.7
(mg/100 g B.W.) 6.8 + 0.5 8.4 ± 0.7 7.8 + 2.2
Cytosolic protein
(mg/g liver) 112± 11 110 + 6 116 -1:15 °
Glycogen (mg/g liver) 5.0 ± 1.0 11.5 -1-2.9 20.7 ± 4.6
Total phospholipids
(I.trnol/gliver) 32,8 + 2.3 35.8 -l-1.9 28.6 + 2.0
Triglycerides
(mg/g liver) 143 ± 11 151 + 11 155 ± 19
Cholesterol (rag/g) 7.03 ± 0.63 5.75 ± 1.46 4.69 + 0.99
Total sphingolipids
(larnol/g liver) 0.60 ± 0.04 0.58 + 0.02 0.62 ± 0.06
Free sphingosine
(nmol/g liver) 4.31 ± 0.80 2.99 ± 0.43 2.93 ± 0.21
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TABLE 2.
Activities of selee_:l cytc_olic liver et_rnes
Vivarium Synchronous Flight
(Mean + SD)
Tyrosine aminotransferase
(gmol/min/mg protein) 8.2g 4- 1.63 6.49 + 2.18 6.69 + 2.01
(mn_i/min/g liver) 0.93 + 0.18 0.71 + 0.24 0.78 + 0.23
Glutathione S-transferase
: (nmol/min/mg protein) 173 + 10 191 4-24 153 + 24
},tmol/min/gliver) 19.4 4- 1.1 21.0 + 2.6 18.9 + 2.8
Cystathionase
(nmol/min/mg protein) 3.20 + 0.46 3.56 + 0.69 3.21 + 0.64
(lamol/min/g liver) 0.36 + 0.05 0.39 4-0.08 0.37 4-0.07
Cystathionine 6-synthase
(nmol/min/mg protein) 3.27 4-0.16 2.99 + 0.82 3,29 4- 0.40
(I.tmol/min/g liver) 0.37 4-0.02 0.33 4-0.09 0.38 4- 0.05
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TABLE 3.
Activities of selected microsomal enzymes of rat liver
Vivaritun Synchronous Hight
(Mean ± SD)
Cytochrome P-450
(nmo_mg) 0.58 4. 0.15 0.77 + 0.12 0.66 4. 0.11
: (nrnol/g liver) 1.62 + 0.4 2.54 4. 0.4 1.58 4-0.26
(nmol/100 g B.W.) 3.91 4. 1.01 6.48 -1-1.01 5.15 + 0.86
Aniline hydroxylase
(units/mg) 0.048 4.0.008 0.050 4. 0 008 0.041 4. 0.008
(units/g liver) 0.134 4-0.022 0.165 4. 0.026 0.098 4. 0.019
(units/!00 g B.W.) 0.039 4.0.006 0.047 + 0.007 0.032 + 0.006
Fatty acyl-CoA synthetase
(nmol/min/mg protein) 34.4 + 6.6 31.6 + 3.5 49.9 4. 2.9
(nmol/rnin/g liver) 96.3 4. 18.5 104 4. 12 119 4- 7
Glycerol 3-phosphate acyltransferase
(nrnol/min/mg protein) 1.23 4-0.18 1.32 4-0.04 1.65 + 0.39
(nmol/min/g liver) 3.44 4-0.50 4.36 4-0.13 3.96 :!:0.94
HMG-CoA reductase(lX/mg) 3.7 4-1.1 4.7 4-2.6 11.3 ± 4.5
(lX/gliver) 10.4 4- 3.1 15.5 ± 8.6 27.1 ± 10.8
(_100 g B.W.) 25.1 4-7.5 39.5 + 5.1 88 4. 35
Serine palmitoyltransferase
(I.t/mg) 26.9 4- 2.2 14.5 ± 2.6 20.5 :t: 2.0
(_g liver) 75.3 4- 6.2 47.9:1:8.6 49.2 4-4.8
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TABLE 4.
SerumAnalyses
Basal Vivarium Synchronous Flight
(Mean 4-SD, n=5)
Albumin 5.24 + 0.17 5.12 + 0.18 4.96 + 0.22 4.92 + 0.27
(g/_)
Total Protein 6.48 5:0.11 6.60 + 0.24 6.40 5:0.24 6.40 + 0.40
(g/_)
Glucose 160 5:6.6 112 + 18 124 5:3.8 154 5:17.2
(mg/dL)
; Total Bili 0.4 5:0 0.32 + 0.11 0.4 + 0 0.4 + 0
(mg/dL)
, BUN 16.8 4- 2.3 17.6 + 1.7 13.6 5:1.7 33.2 5:7.8
r
; (rng/dL)
i Creat 0.525:0.11 0.46-1-0.23 0.60+0.14 0.84_+.0.09
mg/dL)i
AST tSGOT) 179 5:66 163 5:47 193 5:19 284 5:70
UJL)
Alk P'ase 323 5:104 105 5:17 153 5:16 235 5:41
U/L)
LDH 866 5:313 694 + 276 762 5:96 877 + 77
IJ/L)
Calcium 10.9 + 0.1 10.7 + 0.2 10.1 5:0.3 9.9 5:0.4
(mg/dL)
Phosphate 7.48 5:0.41 7.0 + 0.42 5.96 + 0.36 6.60 :t: 0.40
(mg/dL)
K 6.08 4-0.86 6.16 5:0.17 5.36 5:0.09 5.64 5:0.26
(meQ/L)
Cholesterol 62.4 5:3.6 70.8 4-12.0 86.0 5:7.3 128 5:21
(mg/dL)
Trig 182±50 84.84-8.9 1225:15 1425:34
(rag/alL)
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MEAN +/- SE [] SYNCHRONOUS CONTROL
[] COSMOS 1887
I g " ,-
SERUM LIVER
' CHOLESTFROL HMG-CoA REDUCTASE
(mg]dL) (units/g liver)
Figure 1. Comparison of serum cholesterol and liver HMG-CoA reductase activities of rats flown
on Cosmos 1887 and synchronous controls. The actualamounts or units of activity are shown
above the bars.
MEAN +/- SE [] SYNCHRONOUS CONTROL
[] COSMOS 1887
CYTOCHROME P450 ANILINE HYDROXYLASE
(nmol/g liver) (units/g liver)
Figure 2. Comparison of microsomal cytochrome P450and aniline hydroxylase activities of rats
flown on Cosmos 1887 and synchronous controls. The actual amounts or units of acti_ty are
shown above the bars.
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